Quality Measures, All‐Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis

Marina Serper, David E. Kaplan, Justine Shults, Peter P. Reese, Lauren A. Beste, Tamar H. Taddei, Rachel M. Werner – 20 May 2019 – Decompensated cirrhosis is associated with high morbidity and mortality. However, no standardized quality measures (QMs) have yet been adopted widely.

Clinical Utility of a Risk‐Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

Mario Romero‐Cristóbal, Teresa Mombiela, Aranzazu Caballero, Ana Clemente, Ainhoa Fernández‐Yunquera, Fernando Diaz‐Fontenla, Diego Rincón, Cristina Ripoll, Javier Bermejo, María‐Vega Catalina, Ana‐María Matilla, Luis Ibáñez‐Samaniego, José Pérez‐Peña, José‐Ángel López‐Baena, Benjamín Díaz‐Zorita, Francisco Fernández‐Avilés, M. Magdalena Salcedo, Rafael Bañares – 20 May 2019 – The prevalence and management of coronary artery disease (CAD) in liver transplantation (LT) candidates are not well characterized.

Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients

Natalia Riva, Jean‐Baptiste Woillard, Maximiliano Distefano, Matias Moragas, Marcelo Dip, Esteban Halac, Paulo Cáceres Guido, Nieves Licciardone, Andrea Mangano, Andrea Bosaleh, María Teresa Davila, Paula Schaiquevich, Oscar Imventarza – 18 May 2019 – Tacrolimus is the cornerstone in pediatric liver transplant immunosuppression. Despite close monitoring, fluctuations in tacrolimus blood levels affect safety and efficacy of immunosuppressive treatments. Identifying the factors related to the variability in tacrolimus exposure may be helpful in tailoring the dose.

Subscribe to